학술논문
Proteoglycan-4 is correlated with longer survival in HCC patients and enhances sorafenib and regorafenib effectiveness via CD44 in vitro.
Document Type
Article
Author
Source
Cell Death & Disease; Nov2020, Vol. 11 Issue 11, p1-14, 14p
Subject
Language
ISSN
20414889